SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001159036-17-000018
Filing Date
2017-03-24
Accepted
2017-03-24 16:08:08
Documents
10
Period of Report
2016-12-31
Effectiveness Date
2017-03-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A haloproxy2017.htm DEF 14A 800729
2 ceocomp.jpg GRAPHIC 38099
3 executivebonus2017a01.jpg GRAPHIC 60686
4 halologobwa01.jpg GRAPHIC 38428
5 htsignaturea02.jpg GRAPHIC 31598
6 leonhardtsignature2a01.jpg GRAPHIC 413112
7 otherneoscomp.jpg GRAPHIC 38764
8 psuvestinga01.jpg GRAPHIC 66797
9 votingimage1.jpg GRAPHIC 262868
10 votingimage2.jpg GRAPHIC 225431
  Complete submission text file 0001159036-17-000018.txt   2400509
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS INC (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32335 | Film No.: 17712865
SIC: 2836 Biological Products, (No Diagnostic Substances)